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Conclusion: The Oyo state IDSR Malaria surveillance system
is simple, ﬂexible, acceptable and useful, however it is not rep-
resentative, not timely, and data quality is low. There is a need
to channel efforts towards integrating tertiary and private health
facilities into the system, improveondata completeness and timeli-
ness and increase supportive supervision for data quality assurance
to health facilities, to improve feedback to reporting sites at all
levels.
http://dx.doi.org/10.1016/j.ijid.2014.03.992
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Infectious diseases with changing geography
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Background: Human migration during the last decades and the
subsequent spreading of infectious diseases beyond the bound-
aries of their usual habitat changed the diagnostic philosophy of
infectionists and epidemiologists. We present two cases treated in
our clinic with the diagnoses of visceral leishmaniasis and malaria
associated with Crimean hemorrhagic fever.
Methods & Materials: Clinical observation, epidemiological
investigation, laboratory testing with serological and virological
diagnostics were done on the two patients.
Results: Case 1 - A 33 year old man was treated with sero-
logically proved diagnosis, ELISA (+) of visceral leishmaniasis. The
disease started in Tavira, Portugal with fever (up to 39oC) and
headache. Objective status: the patient was intoxicated with, ane-
mic syndrome, splenohepatomegaly, Hb-94g/l, Leuc.-1.95.109/l,
Plt-44.109/l. Hewas treated for 28 dayswithmeglumine antimoni-
ate (amp. 5ml. daily) combined with allopurinol and ketoconazole.
After dynamic tracking the patient was clinically healthy, with
normal laboratory indices. Case 2 – A 39 year old man became
ill 5 days after he return in Bulgaria from Zambia with symp-
toms of fever, headache, myalgia, vomiting and blood and mucous
in diarrhea. Objective status: the patient was in severe state,
intoxicated with craniopharyngeal and hemorrhagic syndromes,
hepatosplenomegaly. Laboratory tests showed anemia, thrombo-
cytopenia and uremia. The thick and thin smears proved tropical
malariawith high number of plasmodium falciparum (224000/l).
The PCR was positive for CCHF. He was treated with hyperim-
mune globulin, artequin and hemostatic drugs. The rarely observed
association between the two diseases led to potentiation amid
immunodepression with the development of cerebral complica-
tions and multiple organ failure with a fatal end.
Conclusion: The early diagnosis and adequate therapy of vis-
ceral leishmaniasis are crucial for its favorite outcome and the
prevention of diagnostic errors with unpredictable effects. The
most important measures are: WHO Global Malaria Programme,
health education, medicine prophylactics of endemically exposed
individuals, detailed epidemiological anamnesis and early etiolog-
ical treatment after the onset of symptoms.
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Background: Monkeypox (MPX) is an acute febrile rash illness
caused by infection with a zoonotic Orthopoxvirus. The disease is
endemic in parts of the Democratic Republic of the Congo (DRC). In
2010, the Centers for Disease Control and Prevention (CDC) part-
nered with the Congolese Ministry of Health to conduct enhanced
surveillance for monkeypox in the Tshuapa Health District. As part
of enhanced surveillance, health-workers investigate suspect cases,
collecting diagnostic samples and information pertaining to signs
and symptoms of illness. Of particular concern are ocular manifes-
tations, which can lead to blindness.
Methods&Materials:Data collectedonMPXpositive casesdur-
ing 2010-2013 were analyzed to gain a better understanding of
ocular complications in relation to demographics and symptoms of
MPX illness. Cases were considered MPX positive if a single diag-
nostic specimen tested positive by real-time PCR at either CDC or
the national laboratory in Kinshasa.
Results: “Conjunctivitis” was reported for a total of 68 (23.1%)
MPX cases. The majority were male (61.7%) and under 10 years of
age (61.8%). 51.8% of the MPX cases that identiﬁed as “non-student
child” and 17% that identiﬁed as “student” had reported “conjunc-
tivitis”. Cases where “conjunctivitis” was reported had a higher
frequency of other symptoms, such as nausea, chills/sweating,
mouth ulcers, sore throat, lymphadenopathy, fatigue, and sensitiv-
ity to light compared to thosewithno reported “conjunctivitis”. 47%
of cases with “conjunctivitis” reported being “bed-ridden”, com-
pared to 16% of cases where “conjunctivitis” was not reported.
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Conclusion: A considerable number of MPX cases (23.1%) had
“conjunctivitis” as a symptom of their illness. The majority of these
were young children (<10 yrs.) who also had a higher frequency
of other symptoms. These individuals were also more likely to be
“bed-ridden”.MPXcaseswith “conjunctivitis” are at risk for corneal
scarring, which can cause blindness. Understanding the underlying
cause of “conjunctivitis” in monkeypox patients will be important,
as somemaybe amenable to treatment (e.g., Triﬂourodine has been
used to treat Orthopoxvirus-associated corneal lesions). Improv-
ing the availability of ophthalmologic resources in areas endemic
for monkeypox may diminish risks for signiﬁcant visual sequelae
among patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.994
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Antiplasmodial activity and acute toxicity of
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Background: According to the WHO, malaria remains a major
health problem emphasized by the reduction of P. falciparum
susceptibility to Artemisinin and derivatives and an increasing
resistanceof vectors to insecticideshighlighting theurgentneed for
new antimalarial leads.This work aimed to discover new antiplas-
modial extract from Cameroonian ﬂora.
Methods & Materials: Crude extract of P. suaveolens (leaves,
stem bark, twigs, stem and trunk) obtained by maceration in
ethanol 95% were subsequently partition between CH2Cl2/H20 and
MeOH90%/Hexane to affordmethanolic fractions (acetogenin–rich
fractions). The Flowcytometry–basedassaywasused todetermine
the IC50 of extract against chloroquine resistant strain of P. falcipa-
rum (W2). A phytochemical screeningwas performed to determine
the group of bioative secondarymetabolites. The safety of fractions
with good activity were assayed on healthy Swiss albino mice by
oral administration at up to 5000mg/kg.
Results: Among twenty extracts from P. suaveolens prepared,
six exhibited a very good activity with IC50 <5g/mL ranged
from 3.212 to 4.530g/mL. Four acetogenin–rich fractions of
twigs, stem-bark, stems and trunk showed a very good activity.
The ethanolic extract of twigs showed inhibiton with a IC50 of
5,754g/mL. Promising fractions (methanol fractions) of P. suave-
olens were safe orally with no death or toxicity signs.
Conclusion: This result support the traditional use of P. suave-
olens to treat malaria and relative symptoms. Meanwhile, further
investigations are required toward the development of new
antmalariadrug using acetogenin-rich fractions of P. suaveolens as
starting material.
http://dx.doi.org/10.1016/j.ijid.2014.03.995
Type: Poster Presentation
Final Abstract Number: 53.037
Session: Infectious Disease Surveillance II
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
School performance after intermittent
preventive treatment using artemisinin-based
combination
H. Maiga1,∗, B. Barger2, I. Sagara1, O. Doumbo1,
A. Djimde1
1 Malaria Research and Training Center, Bamako,
Mali
2 Pediatric Emergency Medicine Fellow, Washington,
USA
Background: Previous studies showed that in areas of seasonal
malaria transmission, intermittent preventive treatment of school
children (IPTsc) targeting the transmission season, reduced the
rates of clinical malaria. The efﬁcacy of ACTs in the context of lon-
gitudinal IPTsc is poorly investigated and school performance has
not been thoroughly evaluated.
Methods & Materials: This was an open randomized con-
trolled trial of seasonal IPT among school children aged 6–13
years in Kolle, Mali. The study began in September 2007 and
completed follow-up in June 2013. Students were randomized to
one of three study arms: Sulphadoxine–pyrimethamine plus arte-
sunate (SP/AS), Amodiaquine plus artesunate (AQ/AS) or Control
(C). All students received two full treatment doses, given 2 months
apart during the season of high transmission from September to
December. Groups were compared with respect to school perfor-
mance, incidenceof clinicalmalaria, asymptomaticparasitemiaand
anaemia.
Results: A total of 296 students were randomized, and reten-
tion in the study was 99.3%. Yearly grade average and success
rate in the SP/AS and AQ/AS arms were (5.37; 79.1%) and (4.87;
70.5%) respectively vs. control (4.81; 68.7%) (P<0.05). Clinical
malaria incidence in the SP/AS and AQ/AS arms was reduced by
50.9% and 20.6%, respectively, vs. control (P<0.001). There were
fewer all-cause clinic visits among the children receiving SP/AS or
AQ/AS (P<0.001). Theprevalenceof asymptomaticparasitemiawas
higher in the control group than in the SP/AS or AQ/AS (P<0.001)
groups. At the end of the transmission period, children treatedwith
IPT showed a trend towards lower rates of anaemia (SP/AS, 4.2%;
AQ/AS, 7.8%; Control, 12.7%;P=0.012).
Conclusion: IPTsc with SP/AS reduced the rates of clinical
malaria, all-cause acute clinic visits and asymptomatic parasitemia
and trended towards a reduction in anaemia among school-aged
children while improving markers of school performance.
http://dx.doi.org/10.1016/j.ijid.2014.03.996
